Your browser doesn't support javascript.
loading
Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.
Martin, Kea; Junker, Ursula; Tritto, Elaine; Sutter, Esther; Rubic-Schneider, Tina; Morgan, Hannah; Niwa, Satoru; Li, Jianping; Schlapbach, Achim; Walker, Dana; Bigaud, Marc; Beerli, Christian; Littlewood-Evans, Amanda; Rudolph, Bettina; Laisney, Marc; Ledieu, David; Beltz, Karen; Quancard, Jean; Bornancin, Frédéric; Zamurovic Ribrioux, Natasa; Calzascia, Thomas.
Afiliación
  • Martin K; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Junker U; Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Tritto E; Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Sutter E; Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Rubic-Schneider T; Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Morgan H; Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Niwa S; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Li J; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Schlapbach A; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Walker D; Preclinical Safety, Novartis Institutes for Biomedical Research, Cambridge, MA, United States.
  • Bigaud M; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Beerli C; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Littlewood-Evans A; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Rudolph B; PK Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Laisney M; PK Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Ledieu D; Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Beltz K; PK Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Quancard J; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Bornancin F; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Zamurovic Ribrioux N; Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Calzascia T; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Front Immunol ; 11: 745, 2020.
Article en En | MEDLINE | ID: mdl-32425939
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Enfermedades Genéticas Ligadas al Cromosoma X / Diabetes Mellitus Tipo 1 / Diarrea / Proteína 1 de la Translocación del Linfoma del Tejido Linfático Asociado a Mucosas / Enfermedades del Sistema Inmune Límite: Animals / Female / Humans / Male Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Enfermedades Genéticas Ligadas al Cromosoma X / Diabetes Mellitus Tipo 1 / Diarrea / Proteína 1 de la Translocación del Linfoma del Tejido Linfático Asociado a Mucosas / Enfermedades del Sistema Inmune Límite: Animals / Female / Humans / Male Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Suiza